JGC
TARO

J. Goldman & Co’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

J. Goldman & Co’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,900
Closed -$286K – 477
2018
Q1 		$286K Buy
+2,900
New +$294K 0.01% 301

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

J. Goldman & Co's TARO Position: Q2 2018 in Review

J. Goldman & Co sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2018, closing a stake of 2,900 shares — an estimated $286K sold.

J. Goldman & Co first reported a position in TARO in Q1 2018 and held it in 1 quarter. The position peaked at $286K in Q1 2018. 109 funds tracked by Wall St. Rank hold TARO as of Q2 2018.

  • J. Goldman & Co reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2018 after selling out during the quarter.
  • J. Goldman & Co sold 2,900 Taro Pharmaceutical Industries Ltd. shares in Q2 2018, an estimated $286K.
  • J. Goldman & Co first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2018 and held it in 1 quarter.
  • J. Goldman & Co's Taro Pharmaceutical Industries Ltd. position peaked at $286K in Q1 2018.
  • 109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2018.

Based on J. Goldman & Co's 13F filing for Q2 2018, filed 14 Aug 2018.